Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Ultimate Plan Preview

Details for Patent: 6,239,173

« Back to Dashboard
Patent 6,239,173 protects VIOXX and is included in two NDAs.

Protection for VIOXX has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

Summary for Patent: 6,239,173

Title: 3-phenyl-4-(4(methylsulfonyl)phenyl)-2-(5H)-furanone as a cox-2 inhibitor
Abstract:The invention encompasses the novel compound of Formula I useful in the treatment of cyclooxygenase-2 mediated diseases. ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.
Inventor(s): Wang; Zhaoyin (Pierrefond, CA), Therien; Michel (Laval, CA)
Assignee: Merck Frosst Canada Inc./Merck Frosst Canada & Co. (Kirkland, CA)
Application Number:09/443,000
Patent Claim Types:
see list of patent claims
Compound; Use; Composition;
Patent PDF download available with subscription

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
SUSPENSION;ORAL021052May 20, 1999DISCNNo6,239,173*PED<disabled>
TABLET;ORAL021042May 20, 1999DISCNNo6,239,173*PED<disabled>
TABLET;ORAL021042Feb 25, 2000DISCNNo6,239,173*PED<disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 6,239,173

Country Document Number Publication Date
Austria212343Feb 15, 2002
Austria165825May 15, 1998
Australia6967494Jan 17, 1995
Australia5621594Jul 04, 1994
Australia3613995May 06, 1996
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013   2014  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2015 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn